nCounter Prep Station 5s NCT-PREP-STATION-FLEX

GUDID 00859812006065

The Prep Station is a part of the nCounter DX Analysis System, which consists of two instruments, the nCounter Prep Station 5s and the nCounter Digital Analyzer 5s. The Prep Station is the automated fluidic handling component of the nCounter DX Analysis System which processes samples post-hybridization. The samples prepared by the Prep Station are used for data collection on the nCounter Digital Analyzer. Together,the NanoString nCounter DX Analysis System (liquid handling robot and epifluorescence scanner) delivers direct, multiplexed measurements of gene expression through digital readouts of the relative abundance of mRNA transcripts using the following steps: 1) a hybridization of the mRNA to fluorescent Reporter Probes and Capture Probes, 2) purification of the target/probe complexes using nCounter Prep Plates containing reagents necessary for post-hybridization processing and immobilization onto the nCounter Cartridge on the nCounter Prep Station, and 3) analysis of the nCounter Cartridge on the nCounter Digital Analyzer to provide a test result.

NANOSTRING TECHNOLOGIES, INC.

Microarray analyser IVD, automated Microarray analyser IVD Microarray analyser IVD Microarray analyser IVD Microarray analyser IVD Microarray analyser IVD Microarray analyser IVD Microarray analyser IVD Microarray analyser IVD Microarray analyser IVD Microarray analyser IVD Microarray analyser IVD Microarray analyser IVD Microarray analyser IVD Microarray analyser IVD
Primary Device ID00859812006065
NIH Device Record Key151140ba-6d99-45ad-9b59-80bcab41c88b
Commercial Distribution StatusIn Commercial Distribution
Brand NamenCounter Prep Station 5s
Version Model NumberNCT-PREP-STATION-FLEX
Catalog NumberNCT-PREP-STATION-FLEX
Company DUNS143888712
Company NameNANOSTRING TECHNOLOGIES, INC.
Device Count1
DM Exemptfalse
Pre-market Exemptfalse
MRI Safety StatusLabeling does not contain MRI Safety Information
Human Cell/Tissue Productfalse
Device Kitfalse
Device Combination Productfalse
Single Usefalse
Lot Batchfalse
Serial Numbertrue
Manufacturing Datefalse
Expiration Datefalse
Donation Id Numberfalse
Contains Natural Rubber Latexfalse
Labeled No Natural Rubber Latexfalse
RX Perscriptiontrue
OTC Over-The-Counterfalse

Customer Support Contacts

Phone1 888-358-6266
Emailinfo@nanostring.com
Phone1 888-358-6266
Emailinfo@nanostring.com
Phone1 888-358-6266
Emailinfo@nanostring.com
Phone1 888-358-6266
Emailinfo@nanostring.com
Phone1 888-358-6266
Emailinfo@nanostring.com
Phone1 888-358-6266
Emailinfo@nanostring.com
Phone1 888-358-6266
Emailinfo@nanostring.com
Phone1 888-358-6266
Emailinfo@nanostring.com
Phone1 888-358-6266
Emailinfo@nanostring.com
Phone1 888-358-6266
Emailinfo@nanostring.com
Phone1 888-358-6266
Emailinfo@nanostring.com
Phone1 888-358-6266
Emailinfo@nanostring.com
Phone1 888-358-6266
Emailinfo@nanostring.com
Phone1 888-358-6266
Emailinfo@nanostring.com
Phone1 888-358-6266
Emailinfo@nanostring.com

Device Identifiers

Device Issuing AgencyDevice ID
GS100859812006065 [Primary]

FDA Pre-market Approvals/Notifications & deNovo

FDA Product Code

NSUInstrumentation For Clinical Multiplex Test Systems

Sterilization

Steralize Prior To Usefalse
Device Is Sterilefalse

Device Entry Metadata

Public Version StatusUpdate
Device Record StatusPublished
Public Version Number4
Public Version Date2019-12-30
Device Publish Date2017-08-16

Devices Manufactured by NANOSTRING TECHNOLOGIES, INC.

00859812006010 - Prosigna Breast Cancer Prognostic Gene Signature Assay2020-02-06 Used together, the Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Dx Analysis System are a nucleic acid hyb
00859812006027 - Prosigna Breast Cancer Prognostic Gene Signature Assay2020-02-06 Used together, the Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Dx Analysis System are a nucleic acid hyb
00859812006034 - Prosigna Breast Cancer Prognostic Gene Signature Assay2020-02-06 Used together, the Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Dx Analysis System are a nucleic acid hyb
00859812006041 - Prosigna Breast Cancer Prognostic Gene Signature Assay2020-02-06 Used together, the Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Dx Analysis System are a nucleic acid hyb
00859812006058 - Prosigna Breast Cancer Prognostic Gene Signature Assay2020-02-06 Used together, the Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Dx Analysis System are a nucleic acid hyb
00859812006003 - nCounter Digital Analyzer 5s2019-12-30 The Digital analyzer is a part of the nCounter DX Analysis System, which consists of two instruments, the nCounter Prep Station
00859812006065 - nCounter Prep Station 5s2019-12-30The Prep Station is a part of the nCounter DX Analysis System, which consists of two instruments, the nCounter Prep Station 5s and the nCounter Digital Analyzer 5s. The Prep Station is the automated fluidic handling component of the nCounter DX Analysis System which processes samples post-hybridization. The samples prepared by the Prep Station are used for data collection on the nCounter Digital Analyzer. Together,the NanoString nCounter DX Analysis System (liquid handling robot and epifluorescence scanner) delivers direct, multiplexed measurements of gene expression through digital readouts of the relative abundance of mRNA transcripts using the following steps: 1) a hybridization of the mRNA to fluorescent Reporter Probes and Capture Probes, 2) purification of the target/probe complexes using nCounter Prep Plates containing reagents necessary for post-hybridization processing and immobilization onto the nCounter Cartridge on the nCounter Prep Station, and 3) analysis of the nCounter Cartridge on the nCounter Digital Analyzer to provide a test result.
00859812006065 - nCounter Prep Station 5s2019-12-30 The Prep Station is a part of the nCounter DX Analysis System, which consists of two instruments, the nCounter Prep Station 5s a

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.